Christopher John Kenney's most recent trade in Xenon Pharmaceuticals Inc was a trade of 80,000 Share Option (Right to Buy) done . Disclosure was reported to the exchange on March 12, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Xenon Pharmaceuticals Inc | Christopher John Kenney | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2025 | 80,000 | 80,000 | - | - | Share Option (Right to Buy) | |
| Xenon Pharmaceuticals Inc | Christopher John Kenney | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2025 | 15,000 | 15,000 | - | - | Restricted Share Units | |
| Xenon Pharmaceuticals Inc | Christopher John Kenney | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2024 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Xenon Pharmaceuticals Inc | Christopher John Kenney | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 35.01 per share. | 24 Mar 2023 | 700 | 0 (0%) | 0% | 35.0 | 24,507 | Common Shares |
| Xenon Pharmaceuticals Inc | Christopher John Kenney | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2023 | 120,000 | 120,000 | - | - | Stock Option (Right to Buy) | |
| Xenon Pharmaceuticals Inc | Christopher John Kenney | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2022 | 125,000 | 125,000 | - | - | Stock Option (Right to Buy) | |
| Xenon Pharmaceuticals Inc | Christopher John Kenney | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 28.81 per share. | 21 Jan 2022 | 700 | 700 (0%) | 0% | 28.8 | 20,167 | Common Shares |
| Xenon Pharmaceuticals Inc | Christopher John Kenney | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Aug 2021 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) |